HOME >Arabinoxylan Compound  ( Bio-bran )・TOP >
Reports of recovery from disease due to MGN-3
Chronic hepatitis,Chronic Hepatitis, Type B, and Liver Cancer(1)(2),Chronic C type virus hepatitis(1)(2)(3),Chronic C type virus hepatitis,stomach cancer,Cirrhosis,,Chronic hepatitis C, liver cancer(1)(2),Chronic Hepatitis, Type C

Diabetes(1),(2),Diabetes (NIDDM),Diabetes (NIDDM), asthma

Breast Cancer(1)(2)(3)(4)(5)(6)(7)(8)(9),Breast cancer (metastasis in the left neck lymph node) ,Breast cancer and metastases in the brain and lung

Hepatitis C(1)(2)|Hepatitis C→liver cancer

Prostate cancer(1)(2)(3)(4)|Colon Cancer(1)(2)(3)(4),Colonic Cancer/Liver Metastasis,Colon polyp|Pulmonary adenocarcinoma(1)(2)|Atopic dermatitis(1)(2)(3)|Articular rheumatism(1)(2)(3) |EndometriosisBladder cancer,Bladder CarcinomaPrimary Malignant Lymphoma of the Left Breast Articular RheumatismLung Cancer/Lib Metastasis,Lung cancer (terminal)Stomach Cancer,Stomach cancer (scirrhous)Liver cancerMetastatic Lung CancerPancreas Cancer, Gallbladder and Liver MetastasisOvarian tumorMalignant liver cancer,Malignant lymphomaInfantile asthmaTonsillitisPharynx cancerOropharynx cancerRectum cancer, bile duct cancerPulmonary adenocarcinoma→metast asis to the pleura

 No. 61 Pulmonary adenocarcinoma→metast asis to the pleura
 AGE/38   SEX/Male   Method of ingesting MGN-3/Immunotherapy
History of past diseases and treatments

Pulmonary adenocarcinoma metastasized to the pleura and the patient was recommended but refused a surgical operation. He switched to a diet centering on fresh vegetables and began to take MGN-3 3g daily (1 g at a time) as an immunopotentiating food. The number of cancer cells dropped in 6 months and the patient attained complete remission in 1 year.

Evaluation of MGN-3

Pulmonary adenocarcinoma metastasized to the pleura but a restricted diet and treatment with an immunopotentiator MGN-3 resulted in a reduction in the size of the cancer lesion and complete remission. The young age and high self-healing potential may have been a contributing factor to the dramatic improvement.


 No. 62  Colon polyp
 AGE/55   SEX/Male   Method of ingesting MGN-3/Immunotherapy
History of past diseases and treatments

A thorough medical examination revealed 3 polyps in the rectum. One was 2 cm in diameter and seemed likely to develop into cancer. He was recommended but refused a surgical operation. He switched to a diet consisting mainly of fresh vegetables and began to take MGN-3 3 g daily (1 g at a time). One month after start of ingestion, the largest of the 3 polyps decreased in size and the remaining 2 polyps were eliminated. After a further 1 month, the large polyp was even smaller.

Evaluation of MGN-3

Polyps disappeared completely within 2 months of treatment with MGN-3. This was largely due to the immunopotentiating effect of MGN-3.


 No. 63  Colon cancer
 AGE/57   SEX/Male   Method of ingesting MGN-3/Immunotherapy
History of past diseases and treatments

Last year, the patient was positive in occult blood test of stool in a municipal regular checkup. He took a complete medical checkup and was diagnosed with colon cancer. He was recommended having an immediate operation but decided to have one 6 months later for the sake of work. He changed his lifestyle and quit smoking and drinking, switched to a diet mainly consisting of fresh vegetables and began to take MGN-3 3 g daily (1 g at a time). There was no increase in tumor markers during the 6 months pending surgery and the colon cancer lesion seemed not to be growing. Laparotomy revealed no metastasis after 6 months and the cancer lesion was found to be smaller. Only a minor operation was necessary to remove a small lesion. Without the need for subsequent chemotherapy, the patient is leading a normal life.

Evaluation of MGN-3

As a result of treatment with MGN-3, the cancer lesion developed no metastasis for 6 months and decreased in size. This was greatly due to the immunopotentiating effect of MGN-3.


 No. 64  Breast cancer
 AGE/48   SEX/Female   Method of ingesting MGN-3/Immunotherapy
History of past diseases and treatments

The patient felt a lump in her breast and visited a hospital for examination. She was diagnosed with breast cancer and recommended a surgical operation because there was a fear of metastasis. During the 3 weeks pending surgery, she switched to a diet mainly consisting of fresh vegetables and took MGN-3 3 g daily (1 g at a time) to enhance immunity. One week after start of treatment, fatigue and the uncomfortable feeling in her chest ameliorated. After 3 weeks, she underwent a complete medical checkup and the result showed the disappearance of the cancer lesion and normal tumor markers. Reexamination performed after 2 months also revealed no abnormal conditions.

Evaluation of MGN-3

During the 3 weeks pending surgery, the patient was put on a restricted diet and given an immunopotentiator MGN-3. The treatment had immediate effect and the cancer lesion disappeared in a short period. The immunopotentiating effect of MGN-3 may have been responsible for this remarkable result.


 No. 65  Breast cancer
 AGE/49 SEX/Female Method of ingesting MGN-3/Immunotherapy
History of past diseases and treatments

In September 2 years ago, the patient felt a lump in the lower part of her right breast and visited a hospital for examination. She was diagnosed with breast cancer. She was recommended but refused an immediate surgical operation. She switched to a diet mainly consisting of fresh vegetables and took MGN-3 3 g daily (1 g at a time) to enhance immunity. The tumor markers began to decrease and the lump in the breast was impalpable after 1 year. A complete medical checkup revealed the elimi

Evaluation of MGN-3

A surgical operation was necessary but the patient was treated with a restricted diet and an immunopotentiator MGN-3 at her strong request. Tumor markers began to decrease when immunity was supposed to have begun improving and disappeared within 1 year. Activation of NK cells by MGN-3 must have produced satisfactory results.


 No. 66  Lung cancer (terminal)
 AGE/52 SEX/Female Method of ingesting MGN-3/Immunotherapy
History of past diseases and treatments

The patient had long had a weak respiratory system and experienced extremely severe coughing and stifling in March 2 years ago. A complete medical checkup revealed terminal lung cancer that was inoperable and left her only 1 year to live. She switched to a diet mainly consisting of fresh vegetables and began to take MGN-3 4 g daily (1 g at a time). One month after start of treatment, attacks of coughing and expectoration decreased, the sense of oppression in the chest began to subside and she became able to do housework. After 6 months, the largest cancer lesion decreased to one-fifth in size and the metastasis disappeared. After 1 year, the cancer disappeared and no metastatic lesion was observed.

Evaluation of MGN-3

The immunopotentiating effect of MGN-3 helped the patient to achieve the miraculous recovery from terminal lung cancer. This case exemplifies the potential self-healing power and the power of MGN-3 that assists it. The patient is taking MGN-3 1 g daily to prevent recurrence.


 No. 67  Colon cancer  Facility/T Hospital
 Patient's name/S. B AGE/64 years SEX/Male AREA/Shizuoka Prefecture
History of past diseases and treatments

In December 1998, the patient found his stool heavily contaminated with blood and visited a nearby hospital to undergo colonoscopy. As a result, he was diagnosed with colon cancer. He was recommended but refused a surgical operation and visited this hospital in January 1999. Although he was also recommended surgery at this hospital, he began to receive, at his strong request, conservative treatment mainly consisting of immunotherapy to prevent cancer growth. He was treated with a restricted diet and a combination of an immunopotentiator MGN-3, other health foods, growth hormone and thymus hormone. MGN-3 was given in a 6-day cycle of 4 successive days of dosing at 5 g/day and 2 days of discontinuity. After 1 year of treatment, he noticed his stool thinning and thought the cancer was growing. As a result of a complete medical checkup, the cancer was not growing but had necrotized completely. The stool was thinner because the mass of a necrotized cancer lesion occluded the colon.

Evaluation of MGN-3

The colon cancer was progressive and needed surgery. Considering QOL, the patient chose to undergo treatment that would enhance self-healing potential. MGN-3 was used to play a leading part in enhancing immunopotency and showed effectiveness as expected. Overall augmentation in self-healing potential eliminated the tumor.


 No. 68  Breast cancer  Facility/T Hospital
 Patient's name/S. O   AGE/62 years   SEX/Female   AREA/Shizuoka Prefecture
History of past diseases and treatments

In August 1999, the patient was operated on to excise a cancer lesion in her right breast. No metastasis was detected on postoperative bone scintigraphy but she was treated with anticancer drugs as a precaution. After 3 months, reexamination with bone scintigraphy revealed cancer lesions in bilateral ribs and scapulae. She was treated with stronger anticancer drugs but she suffered severe adverse effects such as hair loss and vomiting. Chemotherapy was discontinued upon her request and she moved to another hospital that provided alternative medicine. She was treated by incorporating homeopathy and qigong. These treatments proved ineffective for her disease so she left the hospital. While she was looking for other treatments, she attended a lecture where she heard of this hospital. In June 2000, she visited this hospital for examination and treatment. She first underwent coffee enema and was treated with a combination of dietary therapy, an immunopotentiator MGN-3, other health food, growth hormone, thymus hormone and far infrared radiation. MGN-3 was given in a 6-day cycle of 4 successive days of dosing at 5 g/day and 2 days of discontinuity. Coprostasis was excreted when she first underwent coffee enema and she found her general conditions improve as a result of ingestion of the immunopotentiator. She was also given various other foods as part of immunotherapy. She continued taking MGN-3 throughout the treatment. Tumor markers and other test results normalized as her physical condition improved. After 5 months of treatment, tumor markers CA15-3 and CEA were within the normal limits. In March 2001, bone scintigraphy recommended by this hospital revealed complete disappearance of the metastatic lesions and indicated complete remission.

Evaluation of MGN-3

After her immunopotency decreased due to the initial resection for breast cancer, subsequent chemotherapy further diminished her immunopotency. This resulted in recurrence of the disease. Chemotherapy was discontinued considering QOL and she underwent treatment that improved self-healing potential. Cancer lesions disappeared and she achieved complete remission. MGN-3 played a leading role in enhancing immunity and presented effectiveness in the fight against cancer.


Copyright(C)2004 JAFRA. All rights reserved.